Respiratory Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

New Recs for IPF Rx Therapy

Updated guidelines on the treatment of idiopathic pulmonary fibrosis (IPF) by the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association have been published.

Cloud9 Anti-Snoring System Approved

The FDA has cleared its Cloud9 Anti-Snoring System to reduce or eliminate asymptomatic ("simple") snoring in adults.

When Should LABA Therapy Be Stopped?

An article highlights studies on cessation of LABA compared to continued use of LABA/ICS for adults with well-controlled asthma to determine whether stopping LABA treatment has an impact on asthma control, exacerbations, and other serious adverse events.

Soy Supplements for Uncontrolled Asthma

A new study has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Regular Aspirin May Slow Emphysema Progression

Regular aspirin use is associated with a slower progression of early emphysema on computed tomography (CT) scans over the course of 10 years.

Breo Ellipta Inhaler Gains Expanded Indication

GlaxoSmithKline and Theravance announced that the Food and Drug Administration (FDA) has approved Breo Ellipta (fluticasone furoate/vilanterol) for the once-daily treatment of asthma in patients aged ≥18 years.

COPD and Sudden Cardiac Death Risk

Chronic obstructive pulmonary disease (COPD) is already the third leading cause of death in the world, and the condition might also raise a patient's odds for sudden cardiac death.

First Breath-Actuated, Dry-Powder Inhaler for Asthma

Teva announced that the FDA has approved ProAir RespiClick (albuterol sulfate inhalation powder), the first breath-actuated dry-powder inhaler approved for acute asthma symptoms.

News

High-Dose Flu Vaccine Leads to Less Cardio-Respiratory Events in Study

Sanofi Pasteur announced positive results from an analysis of a large-scale, multicenter efficacy trial that evaluated patients who received a higher-dose split-virus inactivated influenza vaccine (IIV-HD; Fluzone High-Dose) vs. a standard-dose split-virus inactivated influenza vaccine (IIV-SD; Fluzone).

Accuracy, Timing of Pre-Op Lung CA Evaluation Can Be Improved

For suspected lung cancer patients, the thoroughness, accuracy, and timeliness of preoperative evaluation could be improved, according to research published in the Annals of Thoracic Surgery.

Telomere Length May Help Predict Lung Cancer Risk

Individuals with long telomeres are at increased risk for lung adenocarcinoma but not other types of cancer, according to a new study.

Routine Dyspnea Severity Assessment Could Aid Care

Regular appraisal in cardiopulmonary disease patients would aid hospitalists' decision making

Featured courses from mycme

Comprehensive Review of Family MedicineExternal web site

This course, directed by Donald B. Middleton, MD, of the University of Pittsburgh Medical Center, ...

CME 57.00 Credits

Grass Allergy Meltaways Do Little for Sinus TroublesExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Untreated Sleep Apnea Boosts Risk of Heart Disease, StrokeExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters